Skip to main content

May 2014

Crack GPAT — Prepare for GPAT Online 

Job for PharmD, JD, Ph.D as Global Regulatory Strategist in Pfizer

Founded in 1849, Pfizer is the world's premier biopharmaceutical company taking new approaches to better health. We discover, develop, manufacture and deliver quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. We also partner with healthcare providers, governments and local communities around the world to expand access to our medicines and to provide better quality health care and health system support. At Pfizer, colleagues in more than 90 countries work every day to help people stay happier and healthier longer and to reduce the human and economic burden of disease worldwide.

Post: Global Regulatory Strategist

Walk in interview in USV - For Production, QA, QC - Only for experienced

We are 2000 cr health care company with operations in India, US & EU, with leadership in diabetes and cardiovascular segments. We provide a supportive and learning, environment where personal growth is encouraged and nurtured. We have three plants based at Daman and Baddi manufacturing Tablets, Capsules: Sterile injectables & Ophthalmic Products, one API plant at Chiplun and biotechnology facility in Nerul Mumbai. All our plants are approved by US, EU, Health Canada and other leading country's regulators.

Job in in HLL Corporate R&D Centre - M.Pharm (2 posts) as SENIOR PROJECT FELLOW (PHARMA)

HLL Lifecare Limited, a Mini Ratna Central Public Sector Enterprise under the Ministry of Health & Family Welfare, Govt. of India is a global provider of high quality healthcare products & services. With state-of-the-art manufacturing facilities spanning across India, HLL is diversifying into vaccine manufacturing, lifecare services, sanitary napkins besides engaging in procurement consultancy, healthcare infrastructure development and facility management.

Post: SENIOR PROJECT FELLOW (PHARMA)- 02

Career as Senior Research Fellow in PGIMER - M.Pharm/ M.S. Pharm

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India Pt.

Job as Project Fellow in Central University of Punjab - M.Pharm. / M.S. (Pharm.)./ M.Sc

The Central University of Punjab, Bathinda (Punjab) has been established through the Central Universities Act 2009 which received the assent of the President of India on 20th March 2009. Its territorial jurisdiction extends to the whole State of Punjab. This newly set up Central University of Punjab (CUP) at Bathinda is poised to write new alphabet on the academic horizon of India.

ECHS invites Radiologist, Surgical Specialist, Medical Specialist, Gynecologist, Medical Officer, Dental Officer, Pharmacist, Dental Hygienist/Tech/Asst, Nursing Assistant, Laboratory Assistant, Laboratory Technician, Physiotherapist, Radiographer, Driver

Retired Armed Forces personnel till 2002 could avail medical facilities only for specific high cost surgery/treatment for a limited number of diseases covered under the Army Group Insurance(Medical Branch Scheme) (AGI(MBS)) and Armed Forces Group Insurance Scheme(Management Information System) (AFGIS (MIS)) schemes. These medicare schemes could provide some relief to the ESM, but it was not a comprehensive scheme as compared to and available for other Central Government Employees. Therefore, the requirement was felt of establishing a medicare system which could provide quality medicare to the retirees of the Armed Forces.

ECHS invites application to engage the following staff on contractual basis at for current financial year, renewable for additional period:

Career as Clinical Research Coordinator in Clini India

Clini India is a progressive and premier academy in clinical research that has rapidly gaining a good reputation for excellence through its innovative approach in clinical research. Clini India is an academy with a good reputation in clinical research industry.

PROJECT SCIENTIFIC OFFICER require in Tata Institute of Fundamental Research

"It is the duty of people like us to stay in our own country and build up outstanding schools of research such as some other countries are fortunate to possess." This was the vision that guided the Tata Institute of Fundamental Research which Homi Bhabha founded. The Institute was founded on 1st June1945 with support from the Sir Dorabji Tata Trust.

BRAIN AS A SANCTURIAN SITE IN DRUG DELIVERY APPROACHES TO IMPROVE BIOAVAILABILITY IN BRAIN

{ DOWNLOAD AS PDF }

ABOUT AUTHOR
Sagar Vishwanath Sonawane*
Dept. of Pharmaceutical Sciences and Technology,
Institute of Chemical Technology,
Matunga, Mumbai, Maharashtra, India.
*sssagarvs@gmail.com

ABSTRACT
Brain is the highly protected organ of the body by the sanctuary known as blood brain barrier (BBB). BBB comprises of tight junctions formed by the closed fenestration network of astrocytes, pericytes microglial cells and endothelial cells. Thus it is very difficult for drug molecules to cross BBB. Thus various approaches are discussed to overcome this barrier. Disruption of BBB was conventional invasive approach. The permeability of BBB increases in various diseases. This increased permeability of BBB is made use for drug trafficking. With advances in nanotechnology, various nanocarrier systems including Polymeric nanoparticles, Micelle, Dendrimer, Liposomes, Solid lipid nanoparticles, Nanostuctured lipid carriers, nanogels, etc. emerged as potential delivery systems.
Administration of inhibitors of p-glycoprotein with drug is another approach. Making lipophilic prodrugs of active drug substances can also be done.
Recently PEGylation of nanoparticles can be done to improve its half life in the body, known as the stealth technology. Further various receptor mediated processes are made use of for transport of nanocarrier across BBB. In this method the nanocarrier is attached to the targeting ligand thus making it receptor specific. The newer concept of molecular Trojan horses is also discussed. Finally the advantages of intranasal drug delivery are emphasized.